425 related articles for article (PubMed ID: 27494946)
1. Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement Fluid.
Janssen PK; Foudraine NA; Burgers DM; Neef K; le Noble JL
Ther Drug Monit; 2016 Dec; 38(6):699-705. PubMed ID: 27494946
[TBL] [Abstract][Full Text] [Related]
2. Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.
Roger C; Wallis SC; Muller L; Saissi G; Lipman J; Lefrant JY; Roberts JA
Antimicrob Agents Chemother; 2016 Aug; 60(8):4901-9. PubMed ID: 27270279
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study.
Philpott CD; Droege CA; Droege ME; Healy DP; Courter JD; Ernst NE; Harger NJ; Foertsch MJ; Winter JB; Carter KE; Van Fleet SL; Athota K; Mueller EW
Pharmacotherapy; 2019 Nov; 39(11):1066-1076. PubMed ID: 31549737
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
Radej J; Krouzecky A; Stehlik P; Sykora R; Chvojka J; Karvunidis T; Novak I; Matejovic M
Ther Drug Monit; 2011 Aug; 33(4):393-7. PubMed ID: 21654349
[TBL] [Abstract][Full Text] [Related]
5. Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution.
Morabito S; Pistolesi V; Tritapepe L; Zeppilli L; Polistena F; Strampelli E; Pierucci A
Crit Care; 2012 Jun; 16(3):R111. PubMed ID: 22738289
[TBL] [Abstract][Full Text] [Related]
6. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
Tiranathanagul K; Jearnsujitwimol O; Susantitaphong P; Kijkriengkraikul N; Leelahavanichkul A; Srisawat N; Praditpornsilpa K; Eiam-Ong S
Ther Apher Dial; 2011 Dec; 15(6):556-64. PubMed ID: 22107692
[TBL] [Abstract][Full Text] [Related]
7. Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients.
Roger C; Cotta MO; Muller L; Wallis SC; Lipman J; Lefrant JY; Roberts JA
Int J Antimicrob Agents; 2017 Aug; 50(2):227-231. PubMed ID: 28689876
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics and dosing simulations of cefuroxime in critically ill patients: non-standard dosing approaches are required to achieve therapeutic exposures.
Carlier M; Noë M; Roberts JA; Stove V; Verstraete AG; Lipman J; De Waele JJ
J Antimicrob Chemother; 2014 Oct; 69(10):2797-803. PubMed ID: 24917580
[TBL] [Abstract][Full Text] [Related]
9. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation.
Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
Int J Artif Organs; 2013 Dec; 36(12):845-52. PubMed ID: 24362894
[TBL] [Abstract][Full Text] [Related]
10. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
[TBL] [Abstract][Full Text] [Related]
11. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding.
Palsson R; Niles JL
Kidney Int; 1999 May; 55(5):1991-7. PubMed ID: 10231464
[TBL] [Abstract][Full Text] [Related]
12. Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs.
Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
BMC Nephrol; 2013 Oct; 14():232. PubMed ID: 24156306
[TBL] [Abstract][Full Text] [Related]
13. Continuous renal replacement therapy: a potential source of calories in the critically ill.
New AM; Nystrom EM; Frazee E; Dillon JJ; Kashani KB; Miles JM
Am J Clin Nutr; 2017 Jun; 105(6):1559-1563. PubMed ID: 28468893
[No Abstract] [Full Text] [Related]
14. Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid.
Morabito S; Pistolesi V; Tritapepe L; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
Hemodial Int; 2013 Apr; 17(2):313-20. PubMed ID: 22882732
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration.
Boucher BA; Hudson JQ; Hill DM; Swanson JM; Wood GC; Laizure SC; Arnold-Ross A; Hu ZY; Hickerson WL
Pharmacotherapy; 2016 Dec; 36(12):1229-1237. PubMed ID: 27862103
[TBL] [Abstract][Full Text] [Related]
16. Population Pharmacokinetic Model-Based Evaluation of Standard Dosing Regimens for Cefuroxime Used in Coronary Artery Bypass Graft Surgery with Cardiopulmonary Bypass.
Alqahtani SA; Alsultan AS; Alqattan HM; Eldemerdash A; Albacker TB
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358296
[TBL] [Abstract][Full Text] [Related]
17. Elimination of levofloxacin in critically ill patients with renal failure: influence of continuous veno-venous hemofiltration.
Bellmann R; Egger P; Gritsch W; Bellmann-Weiler R; Joannidis M; Dunzendorfer S; Wiedermann CJ
Int J Clin Pharmacol Ther; 2002 Apr; 40(4):142-9. PubMed ID: 11996208
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration.
Gao C; Tong J; Yu K; Sun Z; An R; Du Z
Eur J Clin Pharmacol; 2016 Jul; 72(7):823-30. PubMed ID: 27023465
[TBL] [Abstract][Full Text] [Related]
19. The use of regional citrate anticoagulation continuous venovenous hemofiltration in extracorporeal membrane oxygenation.
Shum HP; Kwan AM; Chan KC; Yan WW
ASAIO J; 2014; 60(4):413-8. PubMed ID: 24727536
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and Pharmacodynamics of Linezolid in Patients With Sepsis Receiving Continuous Venovenous Hemofiltration and Extended Daily Hemofiltration.
Zheng J; Sun Z; Sun L; Zhang X; Hou G; Han Q; Li X; Liu G; Gao Y; Ye M; Wang H; Yu K
J Infect Dis; 2020 Mar; 221(Suppl 2):S279-S287. PubMed ID: 32176792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
